Stem Cell Therapy Market worth $330 Million in 2020 Stem Cell Therapy Market worth $330 Million in 202 | Page 10

Stem Cell Therapy Market PH 2438 – Regulatory Landscape, Pipeline Analysis, & Global Forecasts to 2020 1.5 RESEARCH METHODOLOGY(5/6) 1.5.4 ASSUMPTIONS • The identification of the key therapeutic areas in both the autologous and allogeneic stem cell therapy markets is done on the basis of pipeline analysis and primary research • The market size of individual stem cell therapeutics is estimated based on a conservative view that out of three products in Phase III of clinical trials, one will be launched in the next 1 to 3 years • Likewise, out of five products in Phase II of clinical trials, one will be launched in the next 4 to 6 years • Commercialization of stem cell therapies are subjected to high uncertainties so the commercialization of particular therapies can take place in 1 to 2 years from the expected time frame • None of the stem cell therapeutics (except Prochymal from Osiris Therapeutics) have been commercialized till date. Additionally, the revenue generated by Prochymal (approved in May 2012) is also negligible till date. Thus, the stem cell therapy market for 2013 was considered to be zero, which was further validated from primary research 1.5.5 LIMITATIONS • Maximum data points were discussed for 2015 - 2020, considering the fact that major commercialization for stem cell therapy would start in next 1-3 years (primary respondents) • Information obtained from secondary and primary resources for expected launch of individual products is extremely sparse • primaries refused to disclose information about their pipeline stem cell therapy products 1.5 Some RESEARCH METHODOLOGY(6/6) 1.5.6 Key Data from Secondary Sources • Product information (commercialized and pipeline) • Competitive landscape and company profiles • Evolution, key applications, and trends in stem cell therapy • Investor networks in the stem cell industry • Initiatives by government and private organizations with regards to the stem cell industry • Regulatory landscape for stem cells across various countries 1.5.7 Key Data from Primary Sources • Market insights for the overall stem cell industry and the current market scenario • Market drivers, restraints, opportunities, challenges, and their impact over the next 7 years • Competitive landscape and company profiles • Probable year of product launches • Potential markets and regional trends for the stem cell therapy market • Insights on the use of stem cells for various therapeutic applications • Insights on the modes of stem cell therapies (autologous and allogeneic) [email protected] www.marketsandmarkets.com 10